Drug profile · INN
buclizine hydrochloride
BUCLADIN-S
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
buclizine hydrochloride (BUCLADIN-S) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN buclizine hydrochloride
Brand BUCLADIN-S
Route ORAL
Formulation TABLET
Frequently asked questions
What is buclizine hydrochloride?
buclizine hydrochloride (BUCLADIN-S) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for buclizine hydrochloride?
BUCLADIN-S is a marketed brand name for buclizine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of buclizine hydrochloride?
buclizine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.